Ann-Sofie Sternås

Ann-Sofie Sternås is an authorized European Patent Attorney with more than 25 years of experience in IP/patent matters from the pharmaceutical industry, including almost 20 years working as an in-house attorney in “big pharma” companies (Astra/AstraZeneca, Pharmacia). The majority of these years have been spent Ann-Sofie working with IP-related matters from a global perspective, including more than 10 years of heavy involvement in the IP litigation of several blockbuster drugs. From 2012 to 2015, she was employed at the investment company Karolinska Development AB. Ann-Sofie has an in-depth understanding and knowledge of strategic IP matters, with a heavy focus on US legislation, particularly regarding IP matters in the interface between patent legislation and regulatory laws.